Herbert Y. Meltzer

Active 1968–2025

Also published as
HERBERT Y. MELTZER
264
Papers
53,674
Citations
131
h-index
264
i10-index

Citations

Citations per year for Herbert Y. Meltzer1968: 1 citations1969: 1 citations1971: 2 citations1972: 1 citations1973: 8 citations1975: 6 citations1976: 12 citations1977: 5 citations1978: 5 citations1979: 16 citations1980: 10 citations1981: 18 citations1982: 29 citations1983: 19 citations1984: 22 citations1985: 43 citations1986: 33 citations1987: 36 citations1988: 51 citations1989: 70 citations1990: 78 citations1991: 82 citations1992: 98 citations1993: 153 citations1994: 124 citations1995: 224 citations1996: 246 citations1997: 318 citations1998: 277 citations1999: 389 citations2000: 389 citations2001: 401 citations2002: 484 citations2003: 587 citations2004: 473 citations2005: 549 citations2006: 512 citations2007: 578 citations2008: 605 citations2009: 464 citations2010: 551 citations2011: 568 citations2012: 584 citations2013: 467 citations2014: 395 citations2015: 327 citations2016: 317 citations2017: 288 citations2018: 298 citations2019: 844 citations2020: 797 citations2021: 802 citations2022: 544 citations2023: 406 citations2024: 570 citations2025: 258 citations2026: 8 citations1970: no citations, so this year is not shown1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,841 citing papers, 32.3% of this breakdownUnited Kingdom: 1,188 citing papers, 7.9% of this breakdownCanada: 920 citing papers, 6.2% of this breakdownGermany: 828 citing papers, 5.5% of this breakdownChina: 684 citing papers, 4.6% of this breakdownAustralia: 568 citing papers, 3.8% of this breakdownItaly: 558 citing papers, 3.7% of this breakdownJapan: 421 citing papers, 2.8% of this breakdownNetherlands: 401 citing papers, 2.7% of this breakdownFrance: 400 citing papers, 2.7% of this breakdownSpain: 373 citing papers, 2.5% of this breakdownSwitzerland: 231 citing papers, 1.5% of this breakdown
0%32.3%Other 23.8%

Fields

  • Medicine43.1%
  • Neuroscience36.1%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Psychology5.3%
  • Nursing1.6%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other2.6%

Topics

  • Schizophrenia research and treatment10.1%
  • Tryptophan and brain disorders7.9%
  • Neurotransmitter Receptor Influence on Behavior6.4%
  • Neuroscience and Neuropharmacology Research4.6%
  • Stress Responses and Cortisol4.4%
  • Treatment of Major Depression3.7%
  • Other62.9%

Coauthors

All papers

Open in search
  1. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 cited by 1,106

  2. Clozapine Treatment for Suicidality in SchizophreniaInternational Suicide Prevention Trial (InterSePT)

    Authors: - Archives of General Psychiatry 2003 cited by 1,374

  3. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.

    Authors: , , , , , , , , - Biological Psychiatry 1999 cited by 1,486

  4. Cellular changes in the postmortem hippocampus in major depression

    Authors: , , , , , , , , - Biological Psychiatry 2004 cited by 728

  5. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

    Authors: , , , , , , - Journal of Affective Disorders 1995 cited by 629

  6. Lower serum high‐density lipoprotein cholesterol (HDL‐C) in major depression and in depressed men with serious suicidal attempts: relationship with immune‐inflammatory markers

    Authors: , , , , , , , , - Acta Psychiatrica Scandinavica 1997 cited by 361

  7. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

    Authors: , , , , , , , , , , , , , , - Journal of Neuroscience 2019 cited by 102

  8. Update on Typical and Atypical Antipsychotic Drugs

    Authors: - Annual Review of Medicine 2012 cited by 421

  9. Treatment-Resistant Schizophrenia - The Role of Clozapine

    Authors: - Current Medical Research and Opinion 1997 cited by 490

  10. Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology

    Authors: , , , , , , , , , , , , , , , - Cell stem cell 2018 cited by 88

  11. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Drake, Sonia Dollfus, Serdar Dursun, Bjørn H. Ebdrup, Robin Emsley, Emilio Fernández-Egea, Hélio Elkis, Peter Falkai, Wolfgang Fleischhacker, Oliver Freudenreich, Ary Gadelha, Wolfgang Gäebel, Birte Glenthøj, Donald Goff, Ariel Graff‐Guerrero, Jorge Hallak, Alkomiet Hasan, William G. Honer, Philip Homan, Oliver Howes, René S. Kahn, Stefan Kaiser, John M. Kane, James L. Kennedy, Bruce J. Kinon, Euitae Kim, Stephen M. Lawrie, Jimmy Lee, Stefan Leucht, F. Markus Leweke, Jan Libiger, Antony Loebel, James H. MacCabe, Stephen R. Marder, Robert A. McCutcheon, Ingrid Melle, Herbert Y. Meltzer, Armida Mucci, Dieter Naber, Shinchiro Nakajima, Jimmi Nielsen, Oisín O’Brien, Akin Ojagbemi, Christos Pantelis, Joseph Peuskens, Steven G. Potkin, Tiago Reis Marques, Thomas J. Raedler, Gary Remington, Susan L. Rossell, Jose Rubio-Lorente, Gabriele Sachs, Dan Siskind, Cynthia Siu, Iris E. Sommer, Jun Soo Kwon, Takefumi Suzuki, Jaana Suvisaari, Hiroyoshi Takeuchi, Rajiv Tandon, David Taylor, Neil Thomas, Jari Tiihonen, Hiroyuki Uchida, Alp Üçok, Daniel Umbricht, Ganesan Venkatasubramanian, Elias Wagner, James Walters, Chuanyue Wang and 2 more - Schizophrenia Bulletin 2023 cited by 38

  12. Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    Authors: , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 755

  13. Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression

    Authors: , , , , , , - Journal of Neuroscience 1997 cited by 449

  14. Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

    Authors: , , , , , , - Neuropsychopharmacology 2009 cited by 295

  15. Suicide risk in schizophrenia: learning from the past to change the future

    Authors: , , , , , , , , , , , , , , , , , , - Annals of General Psychiatry 2007 cited by 356

  16. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder

    Authors: , , , , , , - Biological Psychiatry 2000 cited by 339

  17. Reduced Glutamatergic Currents and Dendritic Branching of Layer 5 Pyramidal Cells Contribute to Medial Prefrontal Cortex Deactivation in a Rat Model of Neuropathic Pain

    Authors: , , , - Frontiers in Cellular Neuroscience 2016 cited by 93

  18. H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

    Authors: , , , , , , , , - Neuropsychopharmacology 2003 cited by 796

  19. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

    Authors: , , , - The International Journal of Neuropsychopharmacology 2005 cited by 604

  20. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

    Authors: , , , , , , , , , - Schizophrenia Research 2005 cited by 1,139

  21. Serotonin receptors : their key role in drugs to treat schizophrenia

    Authors: , , , - Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003 cited by 774

  22. Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

    Authors: , , , , , , , , , - Journal of Clinical Psychopharmacology 2002 cited by 431

  23. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial*

    Authors: , , , , , , , , , , , , - Critical Care Medicine 2010 cited by 445

  24. Randomized controlled trial of deutetrabenazine for tardive dyskinesia

    Authors: , , , , , , , , , , , , , , - Neurology 2017 cited by 328